Sponsor pipeline

Kallyope Inc. clinical trial pipeline

3 active trials 3 recruiting 3 Phase 3 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 3

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT07816367	A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of…	Migraine	Recruiting	2026-10-07
NCT07674654	A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine	Acute Migraine	Recruiting	2026-08-27
NCT07645924	A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment…	Migraine	Recruiting	2026-08-20

Get alerts when Kallyope Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.